Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin 18 pseudogene 26 (KRT18P26) is a processed pseudogene related to the *KRT18* gene, which encodes keratin 18—a type I intermediate filament protein commonly found in simple epithelial tissues[3][7]. The *KRT18* functional gene is involved in structural support, regulation of apoptosis, cell proliferation, and cancer as a biomarker[1][4][5][6]. However, pseudogenes such as KRT18P26 do not produce functional proteins or participate in these biological activities[3][7]. Pseudogenes typically arise from gene duplication or retrotransposition events and lack essential coding capacity due to mutations or deletions. KRT18P26 has no known biological function, no established role in disease, and no relevance as a drug target or biomarker. KRT18P26 is a pseudogene, not a functional gene, protein, or therapeutic target[3][7]. It should not be considered a receptor, enzyme, or any sort of druggable target. Any reference to KRT18P26 as a functional target is incorrect. Information about the functional *KRT18* gene does not apply to KRT18P26.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin 18 pseudogene 26 (KRT18P26).